United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 14803-162_4b4f151b-556d-74f6-e063-6294a90a3f22
- Product NDC
- 14803-162
- Form
- TABLET
- Composition / generic term
- Guaifenesin
- Labeler
- Elysium Pharmaceuticals Ltd.
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20240207
- Source listing expiry
- 20271231
Source-listed ingredients
- GUAIFENESIN — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30000 TABLET in 1 BOTTLE (14803-162-00) · 14803-162-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →